Salesforce Stock Today: Can Q2 Earnings Extend CRM’s 35% Rebound?

Key Takeaways

• Salesforce will report its fiscal Q2 2027 results after the US market closes on 26 August.
• Wall Street expects revenue of $11.32 billion and earnings of $3.27 per share.
• Agentforce adoption, cRPO growth and second-half guidance could matter more than a modest earnings beat.

Salesforce Q2 earnings: key numbers to watch

Salesforce stock has moved largely sideways ahead of the company’s fiscal second-quarter results, as investors wait for fresh evidence that its artificial intelligence strategy is translating into stronger financial growth.

The cloud software company is scheduled to release its fiscal Q2 2027 earnings after the US market closes on Wednesday, 26 August. Revenue is expected to reach approximately $11.32 billion, representing year-on-year growth of about 11%.

Earnings are forecast at $3.27 per share, which would mark an increase of roughly 12% from the same period a year earlier.

Those headline figures will provide an initial indication of Salesforce’s performance. However, a small revenue or earnings beat may not be enough to produce a sustained rally after the stock’s recent recovery.

CRM shares have climbed approximately 35% from their June low. Even after that rebound, the stock remains around 20% below its 2026 high of roughly $266, reflecting lingering concerns over organic growth, AI competition and the company’s future valuation.

Why Salesforce guidance may matter more than the Q2 results

Management previously indicated that organic growth could strengthen during the second half of fiscal 2027. As a result, the company’s updated outlook is likely to have a greater influence on CRM stock than its backward-looking quarterly results.

Investors will be listening for any changes to full-year revenue and earnings guidance. Commentary on sales pipelines, contract sizes, customer spending and demand across Salesforce’s core cloud products could also shape the market’s reaction.

Current remaining performance obligations, known as cRPO, will be another closely watched metric. It measures contracted revenue that Salesforce expects to recognise over the next 12 months, offering an indication of near-term subscription demand.

Analysts expect cRPO to increase by more than 13% to approximately $33.41 billion. Growth above that level could suggest that enterprise demand remains resilient and that Salesforce is securing enough new business to support an acceleration during the second half of the year.

A weaker result, particularly when adjusted for acquisitions, could renew concerns that the company is relying too heavily on cost controls and share repurchases while its underlying growth remains under pressure.

Agentforce adoption faces a crucial test

Agentforce will likely be at the centre of the earnings call. Salesforce has positioned the platform as a major part of its AI strategy, allowing businesses to deploy autonomous digital agents that can complete customer-service, sales and other workplace tasks.

The market now wants evidence that early interest, pilot programmes and product trials are converting into paid commercial deployments.

Investors may focus on the number of paying Agentforce customers, the size of AI-related contracts and whether existing Salesforce clients are expanding their spending after adopting the platform.

The distinction between customer interest and measurable revenue will be important. Strong trial activity may demonstrate demand, but it will not necessarily support a higher valuation unless Salesforce can show that Agentforce is contributing to contract growth, renewals or additional product adoption.

There is also a broader question surrounding AI disruption. Salesforce benefits from a large enterprise customer base, extensive proprietary business data and an established software ecosystem. However, investors need to see that generative AI strengthens those advantages rather than allowing newer competitors to challenge the company’s core products.

Evidence that Agentforce is adding revenue without weakening Salesforce’s existing subscription business could provide one of the strongest catalysts for CRM stock.

CRM options signal volatility rather than a clear bearish bet

Short-dated options suggest that traders are preparing for a sizeable post-earnings move.

The put-to-call ratio for contracts expiring on 28 August stands at approximately 1.06. This indicates slightly more activity in put options than call options, suggesting a modestly cautious bias heading into the announcement.

However, a ratio close to 1.0 is relatively balanced and does not represent an overwhelmingly bearish position. Options can also be used for portfolio protection, meaning elevated put demand is not necessarily a direct bet that CRM stock will fall.

The lower boundary reflected in current options pricing sits near $193, which would represent a decline of more than 6% from recent levels. That figure should be viewed as part of the market’s expected trading range, rather than a directional price forecast.

Salesforce’s relative strength index is also in the mid-60s. This reflects stronger recent momentum but remains below the conventional overbought threshold of 70. It therefore points to an extended recovery rather than confirming that a sell-off is imminent.

What could move Salesforce stock after earnings?

A positive reaction would likely require more than a narrow earnings beat. Strong cRPO growth, improving organic revenue expectations and concrete evidence of Agentforce monetisation could support the case for a continued recovery.

Clearer guidance showing that AI products are increasing customer spending would also help reduce concerns that Salesforce’s growth rate will remain permanently below its historical levels.

Conversely, weaker cRPO, cautious second-half guidance or limited disclosure on Agentforce revenue could place renewed pressure on the shares. Expectations have risen alongside the stock’s 35% rebound, leaving less room for management to deliver an uncertain outlook.

Salesforce currently trades at a lower valuation than it did around its 2025 highs, potentially giving the stock room to re-rate if growth improves. Wall Street’s average price target is near $252, although analyst targets are not guarantees of future performance.

The 26 August earnings release will ultimately test whether Salesforce’s recovery is supported by improving business fundamentals or has moved ahead of the company’s near-term growth outlook.